Methyl 4-acetamido-2-ethoxybenzoate; Benzoic acid, 4-(acetylamino)-2-ethoxy-, methyl ester; UNII-F4X3L6068O; Methyl 4-(acetylamino)-2-ethoxybenzoate; MFCD00075809; Ethopabat; F4X3L6068O; NCGC00160624-01; DSSTox_CID_26264; DSSTox_RID_81491; DSSTox_GSID_46264; Ethopabate [USP:BAN]; Amprol Plus (veterinary); EINECS 200-414-3; 4-Acetamido-2-ethoxybenzoesaeuremethylester; Ethopabate (USP); Methyl 2-ethoxy-4-acetamidobenzoate; Ethopabate (125mg); KSC496M0F; SCHEMBL540932; CHEMBL458769; ZINC1387; DTXSID6046264; CTK3J6602; HY-B2138; KS-00000YJ8; Tox21 111943; Tox21_111943; ANW-44496; s3707; Methyl 4-acetamido-2-ethoxy-benzoate; AKOS015892662; Tox21_111943_1; CCG-213430; CM12343; CS-8028; NCGC00160624-02; NCGC00160624-03; NCGC00160624-04; AS-11898; Ethopabate 100 microg/mL in Acetonitrile; SY226309; AB0010964; DB-053312; FT-0625739; 4-acetylamino-2-ethoxybenzoic acid methyl ester; D08916; Ethopabate, VETRANAL(TM), analytical standard; M-1751; AB01563313_01; 075E809; 4-Acetylamino-2-ethoxy-benzoic acid, methyl ester; SR-01000944203; Q-201078; Q5404419; SR-01000944203-1; Ethopabate, British Pharmacopoeia (BP) Reference Standard; Ethopabate (4-Acetylamino-2-ethoxy-benzoic acid methyl ester); Ethopabate, United States Pharmacopeia (USP) Reference Standard